Applied DNA Sciences Inc (APDN): Price and Financial Metrics


Applied DNA Sciences Inc (APDN)

Today's Latest Price: $8.11 USD

0.02 (-0.25%)

Updated Jul 10 4:00pm

Add APDN to Watchlist
Sign Up

Overall POWR Rating


POWR Components:

 Trade Grade  Buy & Hold Grade  Peer Grade  Industry Rank


Industry Rank:

Ranked of 304 in Miscellaneous

See all "A" rated Strong Buy stocks

APDN Stock Summary

  • With a year-over-year growth in debt of -32.3%, Applied Dna Sciences Inc's debt growth rate surpasses merely 8.91% of about US stocks.
  • The volatility of Applied Dna Sciences Inc's share price is greater than that of 94.91% US stocks with at least 200 days of trading history.
  • Shareholder yield, a measure of how much is returned to shareholders via dividends and share repurchases, for APDN comes in at -40.8% -- higher than that of just 11.09% of stocks in our set.
  • If you're looking for stocks that are quantitatively similar to Applied Dna Sciences Inc, a group of peers worth examining would be DDD, BIOC, TTPH, CRTO, and INVE.
  • Visit APDN's SEC page to see the company's official filings. To visit the company's web site, go to www.adnas.com.
APDN Daily Price Range
APDN 52-Week Price Range

APDN Stock Price Chart Technical Analysis Charts


APDN Price/Volume Stats

Current price $8.11 52-week high $22.80
Prev. close $8.14 52-week low $2.52
Day low $7.90 Volume 337,619
Day high $8.22 Avg. volume 1,302,670
50-day MA $8.87 Dividend yield N/A
200-day MA $6.19 Market Cap 37.94M

APDN Latest News Stream


Event/TimeNews Detail
Loading, please wait...

APDN Latest Social Stream


Loading social stream, please wait...

View Full APDN Social Stream

Latest APDN News From Around the Web

Below are the latest news stories about Applied Dna Sciences Inc that investors may wish to consider to help them evaluate APDN as an investment opportunity.

Applied DNA +19% on utility expansion with successful EUA amendment

Applied DNA Sciences (APDN) has formed a wholly-owned subsidiary, Applied DNA Clinical Labs, LLC ((ADCL)), dedicated to the commercial development of its tests in Virology, for the detection of COVID-19, and in Oncology, for the detection and enumeration of invasive Circulating Tumor Cells (iCTCs). In mid-May, the company received Emergency Use Authorization...

Seeking Alpha | July 9, 2020

The Daily Biotech Pulse: FDA Nod For Osmotica, OptiNose Strikes Co-promotion Deal, Orphan Drug Designation For AnaptysBio

Here's a roundup of top developments in the biotech space over the last 24 hours:Scaling The Peaks (Biotech Stocks Hitting 52-week Highs July 8) * Akero Therapeutics Inc (NASDAQ: AKRO) * Altimmune Inc (NASDAQ: ALT) * Amicus Therapeutics, Inc. (NASDAQ: FOLD) * AMRYT PHARMA PL/S ADR (NASDAQ: AMYT) (reacted to its ADSs commencing trading on the Nasdaq) * argenx SE - ADR (NASDAQ: ARGX) * Assembly Biosciences Inc (NASDAQ: ASMB) * Biohaven Pharmaceutical Holding Co Ltd (NYSE: BHVN) * Biondvax Pharmaceuticals Ltd - ADR (NASDAQ: BVXV) * Crispr Therapeutics AG (NASDAQ: CRSP) * Cytokinetics, Inc. (NASDAQ: CYTK) * Eli Lilly And Co (NYSE: LLY) * Emergent Biosolutions Inc (NYSE: EBS) * GENMAB A/S/S ADR (NASDAQ: GMAB) * GenMark Diagnostics, Inc (NASDAQ: GNMK) (pre-announced above-co...

Yahoo | July 9, 2020

Applied DNA Forms Clinical Testing Subsidiary to Maximize Utility of FDA EUA-Approved Linea™ COVID-19 Assay Kit and Expands Utility with Successful EUA Amendment

Applied DNA Sciences Inc. (NASDAQ: APDN) ("Applied DNA" or the "Company") a leader in Polymerase Chain Reaction (PCR)-based DNA manufacturing that enables in vitro diagnostics, and pre-clinical nucleic acid-based therapeutic drug candidates, today announced the formation of a wholly-owned subsidiary, Applied DNA Clinical Labs, LLC ("ADCL"), dedicated to the commercial development of its tests in Virology, for the detection of COVID-19, and in Oncology, for the detection and enumeration of invasive Circulating Tumor Cells (iCTCs). With the formation of ADCL, the Company is executing on a strategy to expand its market reach through value-added services complementary to a growing portfolio of diagnostic assays attractive to a broader number of qualified labs. ...

Yahoo | July 9, 2020

Applied DNA Analyst Says Coronavirus Testing, Vaccine Work Could Drive Major Upside

Shares of Applied DNA Sciences Inc (NASDAQ: APDN ), which is in the race to develop a vaccine for the novel coronavirus, offer an attractive buying opportunity, according to H.C. Wainwright. The Applied DNA Analyst: Yi Chen initiated coverage of Applied DNA shares with a Buy rating and $18 price target, suggesting roughly 132% upside from current levels. The Applied DNA Thesis: Applied DNA's LinearDNA large-scale polymerase chain reaction-based manufacturing platform offers many benefits over the limitations of a large-scale plasmid-based circular DNA approach, especially in the areas of speed, scale, safety and customization, Chen said in a Thursday initiation note. (See his track record here .) The company has been producing large … Full story available on Benzinga.com

Benzinga | July 2, 2020

Applied DNA Sciences to join Russell index

Effective at the open on Monday, June 29, Applied DNA Sciences (APDN) will join the Russell Microcap Index....

Seeking Alpha | June 26, 2020

Read More 'APDN' Stories Here

APDN Price Returns

1-mo 12.48%
3-mo 100.74%
6-mo 94.02%
1-year -60.26%
3-year -88.70%
5-year -93.20%
YTD 93.56%
2019 -73.81%
2018 -74.84%
2017 -14.05%
2016 -42.90%
2015 12.11%

Continue Researching APDN

Want to see what other sources are saying about Applied Dna Sciences Inc's financials and stock price? Try the links below:

Applied Dna Sciences Inc (APDN) Stock Price | Nasdaq
Applied Dna Sciences Inc (APDN) Stock Quote, History and News - Yahoo Finance
Applied Dna Sciences Inc (APDN) Stock Price and Basic Information | MarketWatch


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!



Page generated in 0.8602 seconds.